Tobemstomig (Anti-LAG-3 & PD-1)
Tobemstomig is a bispecific antibody targeting PD-1 and LAG-3, designed to enhance T-cell activation. By blocking these immune checkpoints, it promotes a cytotoxic T-cell response and exhibits potential antitumor effects. M.W 145.24 kDa.
| Trivial name | RO 7247669 |
| Catalog Number | A4044 |
| CAS# | N/A |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/tobemstomig.html |